Skip to content

Study to compare two methods for measuring iv fluid requirement during Renal transplant recipient surgery

Comparison of IVC distensibility guided goal directed fluid therapy with conventional fluid therapy in renal transplant recipients- A prospective, randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/044142
Enrollment
34
Registered
2022-07-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N186- End stage renal disease

Interventions

Intervention1: IVC Distensibility guided fluid therapy: Basal intravenous fluid (balanced salt solution) will be given at rate of 2ml/kg/hr. Inferior Vena Cava Diameter can be measured by ultrasound.D

Sponsors

Tapas Kumar SIngh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age : 18 -60 years, 2.Living donor 3.ASA III 4. Undergoing renal transplant under general anaesthesia 5.Informed written consent 6.Easy sonoanatomy for IVC visualisation. 7.No or Less than 500 ml urine output per day

Exclusion criteria

Exclusion criteria: 1.Impaired RV/LV function and ejection fraction or any ischaemic or other structural heart diseases 2.Morbid obesity, 3.Any lesion obscuring sonoanatomy 4.ABO incompatible 5.Central monitoring site other than Superior vena cava

Design outcomes

Primary

MeasureTime frame
Total fluid given in intraoperative period before kidney reperfusionTimepoint: at time just before clamp opening in both groups.

Secondary

MeasureTime frame
Baseline and after surgery P/F ratiosTimepoint: end of surgery;Correlation between IVC distensibility and CVP valuesTimepoint: after intubation & CVP insertion after kidney bed is ready after skin closure;Day 1 and 2 Urine outputTimepoint: end of POD1 and POD 2;Difference in preoperative and post-operative lactate levels and Standard Base Excess in arterial blood gasTimepoint: end of surgery;Fall in creatinine levels till day 5Timepoint: end of POD5;Incidence of acute rejection in 3 months follow upTimepoint: end of three months;Incidence of breathlessness in postoperative periodTimepoint: end of POD1;Max fall in Mean Arterial pressures in one minute post clamp openingTimepoint: at the time of clamp opening;Total Noradrenaline used in intra operative periodTimepoint: at the end of surgery;Use of other vasopressors or inotropes other noradrenalineTimepoint: end of surgery

Countries

India

Contacts

Public ContactTapas kumar singh

SGPGI

singh.tapas1@gmail.com07607908933

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026